159 related articles for article (PubMed ID: 19007658)
1. Chapter 1. Molecular mechanism of type IV collagen-derived endogenous inhibitors of angiogenesis.
Cooke VG; Kalluri R
Methods Enzymol; 2008; 444():1-19. PubMed ID: 19007658
[TBL] [Abstract][Full Text] [Related]
2. Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth.
Hamano Y; Kalluri R
Biochem Biophys Res Commun; 2005 Jul; 333(2):292-8. PubMed ID: 15979458
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppression by p53 is mediated in part by the antiangiogenic activity of endostatin and tumstatin.
Folkman J
Sci STKE; 2006 Sep; 2006(354):pe35. PubMed ID: 17003465
[TBL] [Abstract][Full Text] [Related]
4. Disruption of endothelial cell interactions with the novel HU177 cryptic collagen epitope inhibits angiogenesis.
Cretu A; Roth JM; Caunt M; Akalu A; Policarpio D; Formenti S; Gagne P; Liebes L; Brooks PC
Clin Cancer Res; 2007 May; 13(10):3068-78. PubMed ID: 17505010
[TBL] [Abstract][Full Text] [Related]
5. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
[TBL] [Abstract][Full Text] [Related]
6. Type IV collagen-derived angiogenesis inhibitors.
Mundel TM; Kalluri R
Microvasc Res; 2007; 74(2-3):85-9. PubMed ID: 17602710
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the functions of endogenous angiogenesis inhibitors.
Grant MA; Kalluri R
Cold Spring Harb Symp Quant Biol; 2005; 70():399-410. PubMed ID: 16869777
[TBL] [Abstract][Full Text] [Related]
8. Endogenous inhibitors of angiogenesis.
Nyberg P; Xie L; Kalluri R
Cancer Res; 2005 May; 65(10):3967-79. PubMed ID: 15899784
[TBL] [Abstract][Full Text] [Related]
9. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparins and angiogenesis.
Norrby K
APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
[TBL] [Abstract][Full Text] [Related]
11. Cloning, purification, and characterization of a non-collagenous anti-angiogenic protein domain from human alpha1 type IV collagen expressed in Sf9 cells.
Boosani CS; Sudhakar A
Protein Expr Purif; 2006 Oct; 49(2):211-8. PubMed ID: 16631378
[TBL] [Abstract][Full Text] [Related]
12. Targeting of tumor blood vessels: a phage-displayed tumor-homing peptide specifically binds to matrix metalloproteinase-2-processed collagen IV and blocks angiogenesis in vivo.
Mueller J; Gaertner FC; Blechert B; Janssen KP; Essler M
Mol Cancer Res; 2009 Jul; 7(7):1078-85. PubMed ID: 19584266
[TBL] [Abstract][Full Text] [Related]
13. Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic properties.
Dhanabal M; Jeffers M; LaRochelle WJ; Lichenstein HS
Biochem Biophys Res Commun; 2005 Jul; 333(2):308-15. PubMed ID: 15950186
[TBL] [Abstract][Full Text] [Related]
14. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
Wong ML; Prawira A; Kaye AH; Hovens CM
J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
[TBL] [Abstract][Full Text] [Related]
15. Role of hematopoietic lineage cells as accessory components in blood vessel formation.
Takakura N
Cancer Sci; 2006 Jul; 97(7):568-74. PubMed ID: 16827795
[TBL] [Abstract][Full Text] [Related]
16. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
Beecken WD; Engl T; Jonas D; Blaheta RA
Int J Mol Med; 2009 Feb; 23(2):261-6. PubMed ID: 19148551
[TBL] [Abstract][Full Text] [Related]
17. Update on endogenous inhibitors of angiogenesis.
Sato Y
Endothelium; 2006; 13(2):147-55. PubMed ID: 16728331
[TBL] [Abstract][Full Text] [Related]
18. Ischemic vascular disease and solid cancers: opposing ends of the angiogenic spectrum?
Balasubramanian SP; Reed MW
Med Hypotheses; 2006; 67(6):1317-9. PubMed ID: 16828237
[TBL] [Abstract][Full Text] [Related]
19. Effect of a statin on an in vitro model of endometriosis.
Esfandiari N; Khazaei M; Ai J; Bielecki R; Gotlieb L; Ryan E; Casper RF
Fertil Steril; 2007 Feb; 87(2):257-62. PubMed ID: 17097652
[TBL] [Abstract][Full Text] [Related]
20. Discovery and development of anti-angiogenic peptides: A structural link.
Dings RP; Nesmelova I; Griffioen AW; Mayo KH
Angiogenesis; 2003; 6(2):83-91. PubMed ID: 14739615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
